((3aS,4R,10(1)S)-10,10-dihydroxy-2,6-diiminodecahydropyrrolo[1,2-c]purin-4-yl)methyl acetate

ID: ALA4547737

Chembl Id: CHEMBL4547737

PubChem CID: 146683623

Max Phase: Preclinical

Molecular Formula: C11H18N6O4

Molecular Weight: 298.30

Molecule Type: Unknown

Associated Items:

Names and Identifiers

Canonical SMILES:  CC(=O)OC[C@@H]1NC(=N)N2CCC(O)(O)[C@@]23NC(=N)N[C@@H]13

Standard InChI:  InChI=1S/C11H18N6O4/c1-5(18)21-4-6-7-11(16-8(12)15-7)10(19,20)2-3-17(11)9(13)14-6/h6-7,19-20H,2-4H2,1H3,(H2,13,14)(H3,12,15,16)/t6-,7-,11-/m0/s1

Standard InChI Key:  FYMGGEYPNDYSSU-HFJPGXAFSA-N

Alternative Forms

  1. Parent:

    ALA4547737

    ---

Associated Targets(Human)

SCN7A Tclin Sodium channel protein type VII alpha subunit (136 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
SCN5A Tclin Sodium channel protein type V alpha subunit (3462 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
SCN9A Tclin Sodium channel protein type IX alpha subunit (8393 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Associated Targets(non-human)

Scn4a Sodium channel protein type IV alpha subunit (55 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: YesOral: NoChemical Probe: NoParenteral: No
Molecule Type: UnknownTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Calculated Properties

Molecular Weight: 298.30Molecular Weight (Monoisotopic): 298.1390AlogP: -2.96#Rotatable Bonds: 2
Polar Surface Area: 153.79Molecular Species: BASEHBA: 6HBD: 7
#RO5 Violations: 1HBA (Lipinski): 10HBD (Lipinski): 7#RO5 Violations (Lipinski): 1
CX Acidic pKa: 10.76CX Basic pKa: 9.20CX LogP: -2.08CX LogD: -5.11
Aromatic Rings: Heavy Atoms: 21QED Weighted: 0.21Np Likeness Score: 2.31

References

1. Mulcahy JV, Pajouhesh H, Beckley JT, Delwig A, Du Bois J, Hunter JC..  (2019)  Challenges and Opportunities for Therapeutics Targeting the Voltage-Gated Sodium Channel Isoform NaV1.7.,  62  (19): [PMID:31012583] [10.1021/acs.jmedchem.8b01906]
2. Pajouhesh H, Delwig A, Beckley JT, Klas S, Monteleone D, Zhou X, Luu G, Du Bois J, Hunter JC, Mulcahy JV..  (2022)  Discovery of Selective Inhibitors of NaV1.7 Templated on Saxitoxin as Therapeutics for Pain.,  13  (11.0): [PMID:36385936] [10.1021/acsmedchemlett.2c00378]

Source